ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest drug-discovery news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks drug-discovery across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Magnitude Biosciences, a Durham University spinout and contract research organisation, has secured €1.5 million in funding. The investment will accelerate the commercialisation of VivoScan, its proprietary in vivo high-throughput screening platform for drug discovery.
Summaries by ByteBrief